18,331 Followers on Owler

NuVasive

Read more
J. Christopher Barry's photo - CEO of NuVasive

CEO

J. Christopher Barry

CEO Approval Rating

90/100

Founded:

1997

Status:

PublicIndependent CompanyNASDAQNUVA

NUVASIVE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

NuVasive's company profile
J. Christopher Barry's photo - CEO of NuVasive

J. Christopher Barry

CEO

90/100
2,300
$141.3M
$1.2B
View Profile
1
NuVasive's Competitor - Medtronic logo
Geoffrey S. Martha's photo - Chairman & CEO of Medtronic

Geoffrey S. Martha

Chairman & CEO

95/100
86,000
- -
$31.6B
View Profile
2
NuVasive's Competitor - DePuy Synthes logo
CEO Avatar

Colin Ward

General Manager

71/100
18,000
- -
$8.8B
View Profile
3
NuVasive's Competitor - Stryker logo
Kevin A. Lobo's photo - Chairman & CEO of Stryker

Kevin A. Lobo

Chairman & CEO

93/100
36,000
- -
$16.2B
View Profile
4
NuVasive's Competitor - Zimmer Biomet logo
Bryan C. Hanson's photo - Chairman & CEO of Zimmer Biomet

Bryan C. Hanson

Chairman & CEO

72/100
19,000
- -
$7.9B
View Profile
5
NuVasive's Competitor - Globus Medical logo
David M. Demski's photo - CEO of Globus Medical

David M. Demski

CEO

64/100
1,800
$228.5M
$927.9M
View Profile
6
NuVasive's Competitor - Orthofix logo
Jon Serbousek's photo - President & CEO of Orthofix

Jon Serbousek

President & CEO

85/100
954
- -
$455.6M
View Profile
7
NuVasive's Competitor - K2M logo
Eric Major's photo - Chairman & CEO of K2M

Eric Major

Chairman & CEO

76/100
484
$382.1M
$280.6M
View Profile
8
NuVasive's Competitor - ATEC logo
Patrick S. Miles's photo - Chairman & CEO of ATEC

Patrick S. Miles

Chairman & CEO

71/100
195
$293.4M
$191.5M
View Profile
9
NuVasive's Competitor - Cadwell logo
Patrick Jensen's photo - CEO of Cadwell

Patrick Jensen

CEO

84/100
110
$2M
$10M
View Profile
10
NuVasive's Competitor - Smith & Nephew logo
Roland Diggelmann's photo - CEO of Smith & Nephew

Roland Diggelmann

CEO

79/100
18,581
- -
$5.1B
View Profile
11
NuVasive's Competitor - Integra Lifesciences logo
Peter J Arduini's photo - President & CEO of Integra Lifesciences

Peter J Arduini

President & CEO

87/100
4,500
- -
$1.5B
View Profile
12
NuVasive's Competitor - Align Technology logo
Joseph M. Hogan's photo - President & CEO of Align Technology

Joseph M. Hogan

President & CEO

91/100
11,660
$13M
$3.5B
View Profile

Missing a competitor? Contribute!

Medtronic is NuVasive's #1 rival. Medtronic is a Public company that was founded in Minneapolis, Minnesota in 1949. Like NuVasive, Medtronic also works within the Health Care Equipment field. Medtronic has 87,700 more employees vs. NuVasive.

DePuy Synthes is perceived as one of NuVasive's biggest rivals. DePuy Synthes was founded in 1895, and is headquartered in West Chester, Pennsylvania. DePuy Synthes competes in the Health Care Services field. DePuy Synthes generates $7.6B more revenue vs. NuVasive.

Stryker is a top competitor of NuVasive. Stryker is a Public company that was founded in 1941 in Kalamazoo, Michigan. Like NuVasive, Stryker also competes in the Health Care Equipment space. Compared to NuVasive, Stryker has 40,700 more employees.

NuVasive Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.2B

NuVasive's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 5.8B. Over the last four quarters, NuVasive's revenue has decreased by $-454000. Specifically, in Q2 2021's revenue was $294.8M; in Q1 2021, it was $271.2M; in Q4 2020, it was $291.8M; in Q3 2020, NuVasive's revenue was $295.3M.

NuVasive Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Simplify Medical, Inc.

Feb 2021

Source »
$150M
Simplify Medical is a medical device company that designs and distributes cervical artificial spinal discs for diagnostic imaging applications.
SafePassage Health

Dec 2017

Source »
undisclosed
SafePassage is a provider of intraoperative neurophysiological monitoring services.
Vertera, Inc.

Sep 2017

Source »
undisclosed
Vertera Spine is a medical device company that develops and commercializes interbody implants to address the clinical needs in spinal surgeries.
Biotronic NeuroNetwork, LLC

Jun 2016

Source »
$98M
Biotronic is a patient-centric healthcare organization that provides intraoperative neuro monitoring services to surgeons and healthcare facilities.
MegaSurgical

Feb 2016

Source »
undisclosed
Mega Surgical is an international distributor of NuVasive surgical products, medical instruments, apparatus and equipments.

These are all the companies that NuVasive has acquired. NuVasive has acquired 7 companies and its latest acquisition was Simplify Medical, Inc. in Feb 2021. Simplify Medical is a medical device company that designs and distributes cervical artificial spinal discs for diagnostic imaging applications.

NuVasive Funding History

Since NuVasive was founded in 1997, it has participated in 3 rounds of funding. In total NuVasive has raised $141.3M. NuVasive's last funding round was on Oct 2011 for a total of $40.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Oct 2011
$40.5M
-
IPO
May 2004
$71.5M
-
Equity
May 2001
$29.3M

Since NuVasive was founded in 1997, it has participated in 3 rounds of funding. In total NuVasive has raised $141.3M. NuVasive's last funding round was on Oct 2011 for a total of $40.5M

NuVasive Investments

No recent investments found related to NuVasive

NuVasive News

September 2, 2021MarketScreener

Announces New Executive Leadership Roles (Form 8-K)

(marketscreener.com) NuVasive Announces New Executive Leadership Roles -- New roles strengthen innova... See more »
August 29, 2021San Diego Business Journal

NuVasive's Q2 Earnings Up 45%

San Diego medical device company, NuVasive (NASDAQ: NUVA) recorded $294.8 million in net sales for th... See more »
August 2, 2021Medical Device Network

US FDA approves NuVasive's Pulse platform for spine surgeries

The post US FDA approves NuVasive's Pulse platform for spine surgeries appeared first on Verdict Medi... See more »
August 2, 2021Becker's Spine Review

NuVasive sees back-to-back growth in Q2 - 4 CEO insights

The spine market continued to stabilize in the second quarter as NuVasive reported a 44.8 percent inc... See more »
July 29, 2021MarketScreener

Second Quarter 2021 Release

(marketscreener.com) NEWS RELEASE NuVasive Announces Second Quarter 2021 Financial Results Net sales ... See more »
July 29, 2021Becker's Spine Review

NuVasive net sales up 44.8% in Q2; Pulse platform begins clinical evaluations - 5 notes

NuVasive's net sales in the second quarter increased 44.8 percent year over year to $294.8 million, a... See more »

NuVasive Press Releases

May 3, 2021PR Newswire

NuVasive to Present at Upcoming Investor Conferences

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on ... See more »
January 8, 2021PR Newswire

NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference

SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology... See more »
November 23, 2020PR Newswire

NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on ... See more »
November 3, 2020PR Newswire

NuVasive to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference

SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology... See more »
August 31, 2020PR Newswire

NuVasive to Participate in Investor Events in September 2020

SAN DIEGO, Aug. 31, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technolog... See more »
May 6, 2020StreetInsider

NuVasive Announces First Quarter 2020 Financial Results

SAN DIEGO, May 6, 2020 /PRNewswire/ --Â NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology... See more »
March 10, 2020StreetInsider

Randomized Controlled Trial Results Published in 'Spine' Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion

SAN DIEGO, March 10, 2020 /PRNewswire/ --Â NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technol... See more »

NuVasive Videos

July 26, 2021NuVasive Youtube Channel

"Modulus ALIF animation" on YOUTUBE

July 8, 2021NuVasive Youtube Channel

"NuVasive Innovation Event" on YOUTUBE

July 2, 2021NuVasive Youtube Channel

"Camber animation (Japan)" on YOUTUBE

July 2, 2021NuVasive Youtube Channel

"VP2 animation (Japan)" on YOUTUBE

June 17, 2021NuVasive Youtube Channel

"XLIF Animation (Japan)" on YOUTUBE

June 15, 2021NuVasive Youtube Channel

"The Pulse platform in 2 minutes" on YOUTUBE

Social Media

NuVasive Headquarters

7475 Lusk Boulevard

San Diego, California92121

858-909-1800

Driving Directions »

Trending Companies

NuVasive Summary

ABOUT

Overview

NuVasive develops and commercializes minimally invasive medical devices and products for the surgical treatment of spinal disorders. NuVasive was founded in 1997. NuVasive's headquarters is located in San Diego, California, USA 92121. It has raised 14...

CEO

NuVasive's CEO, J. Christopher Barry, currently has an approval rating of 90%. NuVasive's primary competitors are Medtronic, DePuy Synthes & Stryker.

Frequently Asked Questions about NuVasive

  1. When was NuVasive founded?

    NuVasive was founded in 1997
  2. Who is NuVasive's CEO?

    NuVasive's CEO is J. Christopher Barry
  3. How much revenue does NuVasive generate?

    NuVasive generates $1.2B in revenue
  4. How much funding does NuVasive have?

    NuVasive has historically raised $141.3M in funding
  1. Where is NuVasive's headquarters?

    NuVasive's headquarters is in San Diego California, USA
  2. How many employees does NuVasive have?

    NuVasive has 2,300 employees
  3. What sector does NuVasive operate in?

    NuVasive is in Health Care Equipment
  4. Who are NuVasive's competitors?

    NuVasive's top competitors are Medtronic, DePuy Synthes, Stryker